Annals of urologic oncology (AUO, Ann Urol Oncol, p-ISSN: 2617-7765, e-ISSN: 2617-7773), publishes the results of novel research in the laboratory and clinical settings, including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human urologic oncology with the overall goal of improving clinical care of patients with urologic tumours. It includes three main subjects: bladder, prostate and kidney cancer. In addition, adrenal tumor, testicular cancer, and carcinoma of penis are also considered for the journal subjects.
Indexing Google Scholar, ResearchGate, DOAJ
Current Issue Volume 7 Issue 3, 2024 >>
Editorial board
Editors-in-Chief:
Prostate cancer (PCa) is the most common malignancy in the urinary system. Research suggest that prostate cancer is often accompanied by gene mutation ...
Xuguang Guo
REVIEW | 04 Aug 2024
Sarcomatoid and/or rhabdoid dedifferentiation are rare histopathological findings which may be heterogeneous in renal cell carcinoma. Sarcomatoid ren ...
Sunil V. Jagtap, Shubham S. Jagtap ... Devika Borade
REVIEW | 27 Aug 2024
Bacillus Calmette-Guérin (BCG) is the standard treatment for patients with non-muscle invasive bladder cancer (NMIBC). Although this therapy has been ...
Anusha Gupta, Shiv Verma, Sanjay Gupta
REVIEW | 29 Aug 2024
Systemic treatment, commonly referred to as chemotherapy, is a fundamental approach for treating muscle-invasive bladder cancer (MIBC) and metastatic ...
Haijun Hu, Xianghui Wu
REVIEW | 09 Sep 2024
The clinicopathological significance of KRAS alterations in clinical prostate cancer (PCa) has yet to be comprehensively studied, and the classic KRAS ...
Henry O. Ebili, Sebastian A. Omenai ... Ngozi Chidozie
RESEARCH | 31 Jul 2024
Metastatic prostate cancer, particularly with bone involvement, is a severe form of the disease associated with poor prognosis. Androgen deprivation t ...
TAGANG Titus NGWA-EBOGO, Landry Oriol MBOUCHE ... Fru Forbuzshi ANGWAFO III
RESEARCH | 16 Aug 2024